The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia celss

Jeltje Vries; C.M. Zwaan; Maaike de Bie; Jane Voerman; Monique den Boer; Jacques Dongen; Vincent van der Velden

doi:10.1038/leu.2011.206

The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia celss

Jeltje Vries, C.M. Zwaan, Maaike de Bie, Jane Voerman, Monique den Boer, Jacques Dongen, Vincent van der Velden

Research output: Contribution to journal › Article › Academic › peer-review

105 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	255-264
Number of pages	10
Journal	Leukemia
Volume	26
DOIs	https://doi.org/10.1038/leu.2011.206
Publication status	Published - 2012

Research programs

EMC MM-02-54-03
EMC MM-02-72-01

Access to Document

10.1038/leu.2011.206

http://hdl.handle.net/1765/38266

Cite this

@article{95e13cfffdbd4a069ec9078a29237f7d,

title = "The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia celss",

author = "Jeltje Vries and C.M. Zwaan and {de Bie}, Maaike and Jane Voerman and {den Boer}, Monique and Jacques Dongen and {van der Velden}, Vincent",

year = "2012",

doi = "10.1038/leu.2011.206",

language = "Undefined/Unknown",

volume = "26",

pages = "255--264",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

}

TY - JOUR

T1 - The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia celss

AU - Vries, Jeltje

AU - Zwaan, C.M.

AU - de Bie, Maaike

AU - Voerman, Jane

AU - den Boer, Monique

AU - Dongen, Jacques

AU - van der Velden, Vincent

PY - 2012

Y1 - 2012

U2 - 10.1038/leu.2011.206

DO - 10.1038/leu.2011.206

M3 - Article

SN - 0887-6924

VL - 26

SP - 255

EP - 264

JO - Leukemia

JF - Leukemia

ER -